HNF4A and colorectal carcinoma: Therefore, we performed selective targeting of the Wnt signaling pathway in CRC cells by using ICG-001, a small molecule inhibitor that targets the Wnt signaling pathway by inhibiting TCF/β-catenin-mediated transcription and evaluated its anti-proliferative role in parental and 5FUR CRC cell lines.